Itulazax 12 SQ-Bet Noruega - noruego - Statens legemiddelverk

itulazax 12 sq-bet

alk-abelló as - allergen av bjørkepollen - sublingvalt lyofilisat - 12 sq-bet

Actilyse 10 mg Noruega - noruego - Statens legemiddelverk

actilyse 10 mg

boehringer lngelheim international gmbh - alteplase - pulver og væske til injeksjons-/infusjonsvæske, oppløsning - 10 mg

Actilyse 20 mg Noruega - noruego - Statens legemiddelverk

actilyse 20 mg

boehringer lngelheim international gmbh - alteplase - pulver og væske til injeksjons-/infusjonsvæske, oppløsning - 20 mg

Actilyse 50 mg Noruega - noruego - Statens legemiddelverk

actilyse 50 mg

boehringer lngelheim international gmbh - alteplase - pulver og væske til injeksjons-/infusjonsvæske, oppløsning - 50 mg

Jcovden (previously COVID-19 Vaccine Janssen) Unión Europea - noruego - EMA (European Medicines Agency)

jcovden (previously covid-19 vaccine janssen)

janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vaksiner - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. bruk av denne vaksinen skal være i samsvar med offisielle anbefalinger.

Drovelis Unión Europea - noruego - EMA (European Medicines Agency)

drovelis

gedeon richter plc. - drospirenone, estetrol monohydrate - contraceptives, oral - sex hormoner og modulatorer av genital systemet, - oral contraceptive.

Fatrovax RHD Unión Europea - noruego - EMA (European Medicines Agency)

fatrovax rhd

fatro s.p.a - rabbit hemorrhagic disease virus 2 vp1ab, rabbit hemorrhagic disease virus vp1a - immunologicals for leporidae - kaniner - for active immunisation of rabbits from the age of 28 days to reduce mortality, infection, clinical signs and organ lesions of rabbit haemorrhagic disease caused by rhdv1 and rhdv2.

Calcipotriol/Betamethasone Aristo 50 mikrog/ g / 0.5 mg/ g Noruega - noruego - Statens legemiddelverk

calcipotriol/betamethasone aristo 50 mikrog/ g / 0.5 mg/ g

aristo pharma gmbh - kalsipotriolmonohydrat / betametasondipropionat - gel - 50 mikrog/ g / 0.5 mg/ g

Fingolimod Teva 0.5 mg Noruega - noruego - Statens legemiddelverk

fingolimod teva 0.5 mg

teva gmbh - fingolimodhydroklorid - kapsel, hard - 0.5 mg

Dasatinib Accord Unión Europea - noruego - EMA (European Medicines Agency)

dasatinib accord

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiske midler - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.